Pacira BioSciences PCRX
NASDAQ PCRX
$25.65 +0.26 (+1.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Total Current Liabilities (2010 - 2026)

Updated

Pacira BioSciences' Total Current Liabilities was $122.01 million in Q2 2026, down 61.0% from $313.16 million a year earlier but up 12.2% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Pacira BioSciences came in at $120.59 million, down 61.1% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of -13.8% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $309.92 million in FY2024 (+218.2%), $97.38 million in FY2023 (-34.1%), $147.77 million in FY2022 (-71.6%) and $521.12 million in FY2021 (+105.7%).
  • Quarterly Total Current Liabilities has moved between $92.69 million (Q2 2024) and $521.12 million (Q4 2021) over five years.
  • Compared with a year earlier, Total Current Liabilities has declined for four straight quarters, with growth averaging 83.4% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q2 2025 (growth of 237.9%); the worst was Q4 2022 (a decline of 71.6%).
  • Per Business Quant data, PCRX's Total Current Liabilities in the three quarters before Q2 2026 was $108.79 million (Q1 2026), $120.59 million (Q4 2025) and $107.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Pacira BioSciences 1.01 Bn 73.12 Mn 148.24 Mn 122.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122.01 Mn
Mar 31, 2026 108.79 Mn
Dec 31, 2025 120.59 Mn
Sep 30, 2025 107.08 Mn
Jun 30, 2025 313.16 Mn
Mar 31, 2025 314.73 Mn
Dec 31, 2024 309.92 Mn
Sep 30, 2024 306.40 Mn
Jun 30, 2024 92.69 Mn
Mar 31, 2024 93.44 Mn
Dec 31, 2023 97.38 Mn
Sep 30, 2023 93.66 Mn
Jun 30, 2023 108.91 Mn
Mar 31, 2023 98.70 Mn
Dec 31, 2022 147.77 Mn
Sep 30, 2022 131.53 Mn
Jun 30, 2022 133.18 Mn
Mar 31, 2022 305.07 Mn
Dec 31, 2021 521.12 Mn
Sep 30, 2021 225.79 Mn
API Access

Pacira BioSciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PCRX&period=max&api_key=YOUR_API_KEY